High materiality7/10
Revolution Medicines price target raised to $260 from $259 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst update: Target raised to $260; current price $194.78. Upside remains sizable with a modest increase in target.
- Target $260; price $194.78; upside ~34%.
- Target raised slightly; still attractive vs price.
Key facts
- 01
Target: $260
- 02
Posted price: $194.78
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.